… ProQR Announces Closing of Underwritten Public Offering of … share. All of the shares are being offered by ProQR. The closing included the full exercise of the … securities laws of any such state or jurisdiction. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR to Present Top-Line Results from the Phase 1/2 Study of … Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … from the FDA as well as PRIME access by the EMA. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Therapeutics and Yarrow Biotechnology, an RTW … sectors, and ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the … newly created by RTW, has in-licensed exclusive rights to ProQR’s antisense oligonucleotide technology (ASO) to develop …